D. Western Therapeutics Institute, Inc.
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (13)
D. Western Therapeutics Institute, Inc. made a loss over the last year. D. Western Therapeutics Institute, Inc. owes ¥0.31 for every ¥1 it owns. D. Western Therapeutics Institute, Inc. made a loss in each of the last two years.
Compared with Healthcare companies in Japan · latest annual results Dec 2025.
P/E ratio
LossD. Western Therapeutics Institute, Inc. made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
2.53The share price is 2.53 times D. Western Therapeutics Institute, Inc.'s book value per share, higher than 72% of Healthcare companies in Japan.
Market cap
¥3.6 BThe total market value of all of D. Western Therapeutics Institute, Inc.'s shares at today's price (share price × number of shares), smaller than 86% of Healthcare companies in Japan. PosiCap size class: Micro Cap.
Net worth (book value)
¥1.4 BWhat D. Western Therapeutics Institute, Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
¥24.47Net worth divided by the number of shares. The share price of ¥62.00 is 2.5 times this, which is the P/B above.
Return on equity (ROE)
-55.8%D. Western Therapeutics Institute, Inc. lost 55.8% of its shareholders' money over the last year, lower than 88% of Healthcare companies in Japan.
Owes vs Owns
0.31×D. Western Therapeutics Institute, Inc. owes ¥0.31 for every ¥1 it owns (low), lower than 55% of Healthcare companies in Japan.
Dividend yield
NoneD. Western Therapeutics Institute, Inc. does not currently pay a dividend.
Revenue growth
-18%Revenue fell 18% in the year to Dec 2025, and shrank 5% a year on average over 3 years.
Profit growth
LossD. Western Therapeutics Institute, Inc. made a loss in each of the last two years.
Profit margin
-163.1%D. Western Therapeutics Institute, Inc. lost ¥163 for every ¥100 of revenue.
Interest cover
Not coveredD. Western Therapeutics Institute, Inc.'s operating profit did not cover its interest costs in the year to Dec 2025.
Cash vs debt
Net cashD. Western Therapeutics Institute, Inc. held ¥1.1 B more cash than debt (net cash) at Dec 2025.
Questions
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For D. Western Therapeutics Institute, Inc.: ¥3.6 B ÷ ¥1.4 B (30 Jun 2026) = 2.5.
What is D. Western Therapeutics Institute, Inc.'s return on equity?
D. Western Therapeutics Institute, Inc. lost 55.8% of its shareholders' money over the last year, lower than 88% of Healthcare companies in Japan.
How much does D. Western Therapeutics Institute, Inc. owe compared with what it owns?
D. Western Therapeutics Institute, Inc. owes ¥0.31 for every ¥1 it owns (low), lower than 55% of Healthcare companies in Japan.
Does D. Western Therapeutics Institute, Inc. pay a dividend?
No. D. Western Therapeutics Institute, Inc. does not currently pay a dividend.
Is D. Western Therapeutics Institute, Inc.'s revenue growing?
Revenue fell 18% in the year to Dec 2025, and shrank 5% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.